These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. [Antithrombin III and fibrinolysis during pregnancy and oral contraceptive therapy]. Laursen B; Herbst TV; Ewald EC; Pedersen SC Ugeskr Laeger; 1976 Feb; 138(6):344-8. PubMed ID: 56073 [No Abstract] [Full Text] [Related]
35. Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case report. Cieśla-Dul M; Gaweda B; Wypasek E; Rózańska M; Sadowski J Pol Arch Med Wewn; 2009 Dec; 119(12):822-5. PubMed ID: 20010469 [TBL] [Abstract][Full Text] [Related]
36. [Cryofibrinogenemia as an etiological factor in cerebral thrombophlebitis. Apropos of a case]. Chazot G; Dumas R; Creyssel R; Girard PF Rev Neurol (Paris); 1971 Apr; 124(4):269-75. PubMed ID: 5093985 [No Abstract] [Full Text] [Related]
37. [MUTILATING CRYOPATHY WITH PRESENCE OF CRYOFIBRINOGEN IN THE BLOOD]. HARMEL-TOURNEUR L; KALIS B Bull Soc Fr Dermatol Syphiligr; 1964; 71():663-5. PubMed ID: 14266372 [No Abstract] [Full Text] [Related]
38. Oral contraceptives, blood clotting and thrombosis. Poller L Br Med Bull; 1978 May; 34(2):151-6. PubMed ID: 350338 [TBL] [Abstract][Full Text] [Related]
39. I. CRYOPROTEINEMIAS. 2. PRIMARY CRYOFIBRINOGENEMIA--ITS ASSOCIATION WITH CRYOPATHY AND TELANGIECTASIS. RITZMANN SE; LEVIN WC; IVERS JB; KOCH JL Tex Rep Biol Med; 1963; 21():567-80. PubMed ID: 14087158 [No Abstract] [Full Text] [Related]
40. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents. Gordon EM; Douglas J; Ratnoff OD J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]